| Financial Year |
March 31 2023 |
| Monetary Funds |
10,315,660,999.04 |
| Held-for-trading Financial Assets |
137,865,834.96 |
| Notes Receivable |
206,957,875.43 |
| Accounts Receivable |
1,932,854,207.36 |
| Advances to Suppliers |
2,782,284,391.00 |
| Other Receivables |
795,546,700.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
6,000,000.00 |
| Inventories |
16,929,181,429.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
356,804,480.04 |
| Total Current Assets |
33,457,155,918.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
26,512,204,000.62 |
| Investment Properties |
170,881,414.52 |
| Fixed Assetes |
35,886,137,499.06 |
| Under-construction Projects |
20,588,739,823.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
7,180,981,397.26 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,887,330,821.37 |
| R&D expenses |
24,472,094.71 |
| Goodwill |
1,209,971,223.09 |
| Long-Term Deferred and Prepaid Expenses |
148,891,007.03 |
| Deferred Income Tax Assets |
592,214,206.28 |
| Other Non-Current Assets |
973,885,469.06 |
| Sub-Total of Non-Current Assets |
101,320,720,932.35 |
| Total Assets |
134,777,876,850.78 |
| Short-Term Loans |
17,426,041,631.98 |
| Trading Financial liabilities |
28,592,519.68 |
| Notes Payable |
2,933,147,996.97 |
| Accounts Payable |
9,447,857,607.08 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,097,341,348.09 |
| Taxes Payable |
364,296,843.03 |
| Interest Payable |
-- |
| Dividend Payable |
17,271,539.78 |
| Other payables |
4,346,888,338.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,386,075,819.78 |
| Other Current Liabilities |
67,151,786.55 |
| Sub-Total of Current Liabilities |
50,430,981,741.97 |
| Long-term Loans |
28,874,374,237.99 |
| Bonds Payable |
10,191,727,169.26 |
| Long-Term Accounts Payable |
160,676,963.47 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
73,326,583.07 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
44,447,766,230.47 |
| Total Liabilities |
94,878,747,972.44 |
| Paid-In Capital(Or Share Stock) |
4,538,320,386.00 |
| Capital Surplus |
9,915,579,549.77 |
| Surplus Reserve |
3,450,635,038.83 |
| LESS:Treasury Stock |
1,071,693,650.36 |
| Undistributed Profits |
7,766,495,339.34 |
| Minority Stockholder's Interest |
13,161,502,912.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
26,737,625,965.71 |
| Owner's Equity（Stockholder's Equity） |
39,899,128,878.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
134,777,876,850.78 |
